Plain-English translation of NCT03308474 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →MYRIAM is a long-term study that tracks how patients with multiple myeloma (a blood cancer) are treated in real-world medical settings across Germany. Rather than testing a new drug, this study collects information from patients receiving standard treatments to understand which treatment paths work best and how patients' quality of life changes over time. The goal is to learn from what's actually happening in clinics so doctors can make better treatment decisions in the future.
Doctors treat multiple myeloma in many different ways, and the field is constantly evolving. This registry helps researchers understand which treatment sequences are most common, how treatments change over time, and what outcomes patients experience—information that can guide better care decisions for future patients.
You likely qualify if…
You likely don't qualify if…
You would share your medical information with the registry at the start and then periodically over up to five years. This includes details about your diagnosis, previous treatments, current treatments, any side effects, and how you're doing. If you choose to participate in the quality-of-life survey part, you would also complete questionnaires about your health and well-being. Most information is collected from your doctors' records rather than requiring extra visits.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Germany
Sponsor
iOMEDICO AG
Collaborators
Deutsche Studiengruppe Multiples Myelom (DSMM)
Enrollment target
~2,200 participants
Started
September 2017
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Martina Jänicke, PhD
Wuerzburg University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.